Cannabis Investor NewsSubscribe →
C
CIN Terminal
Cannabis Investor News
A CanIDeal Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home › Markets › Loading…
— —

Chicago Atlantic Real Estate Finance

—
—
Live Price

CIN RESEARCH · DATED EVIDENCE

Dated financial evidence

Chicago Atlantic Real Estate Finance: revenue expanded; follow the cash evidence.

The reported-period revenue series records USD 15.22m for the period ended June 30, 2026. That is 4.3% above the same reporting basis a year earlier. Cash and operating cash flow are available on a matching dated basis.

Latest financial observation 2026-06-30Last reported price 2026-11-06Research checked 2026-11-06 13:31 UTC

The check time records a research refresh. Each financial figure and price keeps its own reporting date.

Compare like-for-like revenue

The reported-period revenue series records USD 15.22m for the period ended June 30, 2026. That is 4.3% above the same reporting basis a year earlier.

Read the bottom-line result

The matching reported-period net income is USD 7.47m. This is the reported result for 2026-06-30, not a future earnings estimate.

Put cash beside operating cash flow

Period-end cash was USD 13.35m at 2026-06-30. The matching reported-period operating cash inflow was USD 9.06m. Later financing and cash movements are not established by this snapshot.

Follow the primary disclosures

The available record includes 2 primary disclosures. The latest is 2026-07-13. This is the available feed record, not a claim of complete filing coverage.

Reported financial evidence

Latest retained observation for each measure. Reporting periods and currencies can differ.
MeasureReported value & unitPeriod & intervalEvidence basis
RevenueUSD 15.22mUnit: USDQuarterly seriesDated financial series
Cost of revenueUSD 1.6mUnit: USDQuarterly seriesDated financial series
Gross profitUSD 13.61mUnit: USDQuarterly seriesDated financial series
Operating incomeUSD 9.86mUnit: USDQuarterly seriesDated financial series
EBITDAUSD 9.86mUnit: USDQuarterly seriesDated financial series
Net incomeUSD 7.47mUnit: USDQuarterly seriesDated financial series
Cash balanceUSD 13.35mUnit: USDBalance at period endDated financial series
Total assetsUSD 461.7mUnit: USDBalance at period endDated financial series
Total liabilitiesUSD 160.05mUnit: USDBalance at period endDated financial series
Shareholders’ equityUSD 301.65mUnit: USDBalance at period endDated financial series
Operating cash flowUSD 9.06mUnit: USDQuarterly seriesDated financial series
Free cash flowUSD 9.06mUnit: USDQuarterly seriesDated financial series

A balance at period end is not income over a period. “Quarterly series” follows the available classification; the source disclosure establishes the actual reporting interval.

What changed against the prior year

Only the same measure, unit, reporting frequency and prior-year period end are compared. A reported change is not an investment rating.

Revenue · Quarterly series

Increased +4.3%

2025-06-30
USD 14,589,987
2026-06-30
USD 15,219,022
Cost of revenue · Quarterly series

Decreased -17%

2025-06-30
USD 1,932,957
2026-06-30
USD 1,604,328
Gross profit · Quarterly series

Decreased -6.7%

2025-06-30
USD 14,589,987
2026-06-30
USD 13,614,694
Operating income · Quarterly series

Decreased -10%

2025-06-30
USD 10,954,423
2026-06-30
USD 9,857,703
EBITDA · Quarterly series

Decreased -10%

2025-06-30
USD 10,954,423
2026-06-30
USD 9,857,703
Net income · Quarterly series

Decreased -15.8%

2025-06-30
USD 8,877,375
2026-06-30
USD 7,473,326
Cash balance · Balance at period end

Decreased -62.5%

2025-06-30
USD 35,562,084
2026-06-30
USD 13,351,699
Total assets · Balance at period end

Increased +1.4%

2025-06-30
USD 455,214,325
2026-06-30
USD 461,699,086
Total liabilities · Balance at period end

Increased +10.2%

2025-06-30
USD 145,185,935
2026-06-30
USD 160,051,048
Shareholders’ equity · Balance at period end

Decreased -2.7%

2025-06-30
USD 310,028,390
2026-06-30
USD 301,648,038
Operating cash flow · Quarterly series

Increased +40.1%

2025-06-30
USD 6,463,337
2026-06-30
USD 9,055,362
Free cash flow · Quarterly series

Increased +40.1%

2025-06-30
USD 6,463,340
2026-06-30
USD 9,055,362

What to investigate next

  • Resolve the conflicting financial observations against the primary report.
  • Read the latest linked company disclosures and any reporting after the financial period.
  • Check post-period financing, share issuance and changes in cash before drawing a current valuation conclusion.

Evidence boundaries

  • Conflicting observations for the same concept, period and reporting basis are withheld.
  • Interim frequency is provider-classified. Generic form labels are not treated as proof of an SEC filing or a three-month reporting duration.
  • The earlier rating is not presented as a current conclusion. This report is rebuilt from dated evidence.

Primary company disclosures

Independent evidence summary. No broker consensus, price target or investment rating is manufactured. Research standards →

Price History · USD 5 Years
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

CONTINUE YOUR RESEARCH

Connect the next piece.